Concepedia

Author

Vera Kadlecek

Valneva (Austria)

Also Known As

Vera Kadlecek

10

Publications

166

Citations

7

H-Index

10

Concepts

All Affiliations

Valneva (Austria)Medical University of ViennaResearch Institute for Tropical MedicineVienna BiocenterPhilippine General Hospital
VK

About

Vera Kadlecek is an author at Valneva (Austria) specializing in vaccination, medicine, and vaccine efficacy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

62

2

Epidemiology

1

1

25

3

Immunology

1

1

37

4

Precision Vaccinology

1

1

37

5

Vaccine Development

1

1

37

Vera Kadlecek

×

7

Publications

151

Citations

7

H-Index

YearCitations

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

Nicole Bézay, Romana Hochreiter, Vera Kadlecek,

The Lancet Infectious Diseases

2023

37

Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies

Nicole Bézay, Laura Danielle Wagner, Vera Kadlecek,

The Lancet Infectious Diseases

2024

25

Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region

Katrin Dubischar, Vera Kadlecek, Benjamin Sablan,

The Pediatric Infectious Disease Journal

2017

21

Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study

Tomáš Jelı́nek, Michael A. Cromer, Jakob P. Cramer,

Travel Medicine and Infectious Disease

2018

21

Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children

Katrin Dubischar, Vera Kadlecek, Benjamin Sablan,

The Pediatric Infectious Disease Journal

2017

18

Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose

Vera Kadlecek, Charissa Borja-Tabora, Susanne Eder-Lingelbach,

The Pediatric Infectious Disease Journal

2018

17

Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial

Santhosh Kumar Ghadge, Martina Schneider, Katrin Dubischar,

The Lancet Infectious Diseases

2024

12

Page 1